Sweden-based Qbtech announced that FDA has cleared its online ADHD test, QbCheck, that provides objective and unbiased decision-making support when diagnosing and treating ADHD in children, adolescents and adults. It is the only online ADHD test in the world cleared by the FDA as well as CE marked for this usage.
Traditionally, a clinical interview and subjective information from various rating scales have been the clinical standard. This process is complex, involves administrative costs for the clinic and can extend the time to evaluate if treatment is working. In contrast, QbCheck provides unbiased and objective outcome measurements that can be utilized quickly and easily so that professionals are informed to act in ADHD.
The online test measures the three core signs of ADHD – hyperactivity, inattention and impulsivity. The test taker’s results are compared with norm data from groups of people of the same sex and age with and without ADHD.
QbCheck is based on the same proven technology as QbTest, a test performed by approximately 250,000 patients in Europe and the US. Additionally, the included ADHD Total Symptom Score simplifies the process to identify the test taker’s likelihood of having ADHD-like symptoms.
All being said, the tool is deemed ideal for smaller clinics, schools, rural providers and other qualified professionals who could provide their patients and clients access to the latest medical technology without extra effort. It is launching in the UK with other countries following during the summer and fall.
Qbtech was founded in 2002, and today it has operations in 11 countries and has offices in Stockholm, Atlanta, Frankfurt and London.